John Maris
MD
Professor of Pediatrics
👥Biography 个人简介
John Maris has been central to advancing immunotherapy for high-risk neuroblastoma, contributing to the clinical development of anti-GD2 antibody therapy including dinutuximab that has significantly improved survival outcomes. His neuroblastoma genomics research has identified therapeutic vulnerabilities exploitable through immunotherapy combinations and precision medicine approaches. He leads national cooperative group trials evaluating next-generation immunotherapies for neuroblastoma.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 John Maris 的研究动态
Follow John Maris's research updates
留下邮箱，当我们发布与 John Maris（Children's Hospital of Philadelphia）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment